NEW YORK, NY--(Marketwire - March 31, 2008) - Daxor Corporation, (AMEX: DXR), a medical instrumentation and biotechnology company, today announced earnings for the year ended December 31, 2007. The Company had Net Income of $2.33 per share in 2007 vs. a loss of ($0.17) cents in 2006. This is attributed to the increase in income from investments to $17,389,110 in 2007 from $4,651,140 in 2006. The increased ratio of investment income to operating income triggered personal holding company tax. Income tax expense for 2007 was $1,311,024 vs. $11,750 in 2006. At December 31, 2007, the Company had total assets of $102,560,500 and stockholders’ equity of $54,915,885 vs. total assets of $78,166,312 and $45,637,792 of stockholders’ equity at December 31, 2006.
